Autism

South Carolina is sending a medical cannabis bill to the House floor for consideration.

Kentucky’s GOP-controlled House of Representatives voted 59-64 to pass a bill giving patients with certain severe illnesses access to a state medical cannabis program.

The Ohio House Health Committee approved a bill to add autism spectrum disorder to the state’s medical cannabis qualifying conditions list.

A recent study found significant improvement in autism symptoms following treatment with THC-rich cannabis oil.

A recent study by the Ottowa Hospital in Ontario, Canada suggests that cannabis use during pregnancy can increase the risk of autism.

GW Pharmaceuticals is partnering up with New York’s Montefiore Medical Center to study CBDV, or cannabidivarin, as a treatment for autism.

New Mexico has added six new conditions to the qualifying conditions list for the state’s medical cannabis program. The added conditions include opioid addiction, Alzheimer’s disease, autism, and three neurological disorders.

Researchers at the University of Washington are investigating the efficacy of CBD for Fragile X syndrome, a type of autism that may be linked to cannabinoid deficiencies.

Colorado Gov. Jared Polis is expected to sign the state’s new cannabis-for-autism bill as lawmakers consider additional reforms, including options for social use and cannabis delivery businesses.

In the study, more than 80 percent of children with autism saw moderate to substantial improvement of their symptoms.

A similar bill was vetoed last year, but Colorado’s new Gov. Jared Polis supports adding the condition.